-
Sustainable medicines packaging awards shortlist announced
Finalists showcase innovations in sustainable pharmaceutical packaging, with winners to be announced at Connect in Pharma London, UK, 25th May 2023 / Sciad Newswire / YewMaker and Connect In Pharma announce today the shortlisted finalists for this year’s Sustainable Medicines Packaging Awards. Winners will be announced at an in-person champagne ceremony at Connect In Pharma, an annual event connecting innovators in pharma and biotech…
-
Connect in Pharma launches partnerships for global health innovation
London, UK, 16th May 2023 / Sciad Newswire / Connect in Pharma announce today that for every visitor to the 2023 Geneva-based event, five Swiss francs will be donated to Global Health Security (GHS) Fund, a non-profit organisation driving local innovation and global programming to address threats to health security. Connect in Pharma, taking place 14 & 15 June 2023 in Geneva, brings…
-
Poster Presentation shows insight into Laverock Therapeutics’ platform for cell based therapeutic development
London, UK, 15th May 2023 / Sciad Newswire / Laverock Therapeutics Ltd today announces that a key update on its proprietary and differentiated gene editing induced gene silencing (GEiGS) platform will be featured at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) taking place May 16-20, 2023, in Los Angeles. The data that will…
-
Poster presentation demonstrates the differentiated profile and broad applicability of the company’s gene silencing platform
London, UK, 15th May 2023 / Sciad Newswire / Laverock Therapeutics Ltd today announces that a key update on its proprietary and differentiated gene editing induced gene silencing (GEiGS) platform will be featured at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) taking place May 16-20, 2023, in Los Angeles. The data that will be…
-
BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S
Taipei, Taiwan, 10th May 2023 / Sciad Newswire / BRIM Biotechnology, Inc. (“BRIM,” TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that the Board of Directors has approved a seasoned equity offering that will issue 20 to 22.5 million shares of new stocks priced at 60-80 New Taiwan Dollars (~USD…
-
MultiOmic Health closes $6.2 million funding round to discover precision medicines for metabolic syndrome-related conditions
London, UK, 4th May 2023 / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, has closed a £5 million (US$6.2 million) seed funding extension round to build its precision therapeutics discovery platform for metabolic syndrome-related medical conditions. The round was led by London-based Hoxton Ventures, with participation from Ada Ventures, MMC Ventures and Verve Ventures. Since beginning operations in May…
-
New Talent Equity® Report shows how life sciences organisations are using hybrid working to their advantage
London, UK, 3rd May 2023 / Sciad Newswire / The RSA Group, a leading life sciences executive search firm, has published the latest of its Talent Equity® Reports: No turning back – an analysis of the hybrid working models that have emerged from the pandemic and how they have enabled positive changes to leadership, team dynamics and recruitment…
-
Flexicon’s integrated solution for Müggenburg Pharma’s filling line increases capacity for high-value product
Müggenburg Pharma offers pharmaceutical, food, and cosmetic companies expertise in commercial processing of natural highly controlled raw materials from initial idea and recipe development, through to the control of raw and end product. “Our goal is to offer our customers the shortest possible lead time and time-to-market,” said Christopher Eggerstedt, Head of Product Development and…
-
Domainex secures a prestigious King’s Award for Enterprise
Cambridge and Saffron Walden, UK, 21st April 2023 / Sciad Newswire / Domainex is honoured to announce it has received a King’s Award for Enterprise: International Trade 2023. This prestigious award recognises the company’s outstanding growth in international trade over three years (2019-2021) which amounted to a more than one hundred per cent increase in international revenues during the period. This growth was…
-
Pharmaceutical Industry Needs More Cross-Sector Collaboration
Connect in Pharma is promoting a new era of cross-sector collaboration within the pharmaceutical industry London, UK, 18 April 2023 / Sciad Newswire / The newly announced agenda for Connect in Pharma sends a strong message for more cross-sector collaboration. Technology gurus, consultancy experts and motivational speakers from a wide range of industries are calling for a new, modern era…